Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.

Payne BA, Hutcheon JA, Ansermino JM, Hall DR, Bhutta ZA, Bhutta SZ, Biryabarema C, Grobman WA, Groen H, Haniff F, Li J, Magee LA, Merialdi M, Nakimuli A, Qu Z, Sikandar R, Sass N, Sawchuck D, Steyn DW, Widmer M, Zhou J, von Dadelszen P; miniPIERS Study Working Group.

PLoS Med. 2014 Jan;11(1):e1001589. doi: 10.1371/journal.pmed.1001589. Epub 2014 Jan 21.

2.

External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries.

Ukah UV, Payne B, Lee T, Magee LA, von Dadelszen P; fullPIERS and miniPIERS Working Groups.

Hypertension. 2017 Apr;69(4):705-711. doi: 10.1161/HYPERTENSIONAHA.116.08706. Epub 2017 Feb 6.

PMID:
28167685
3.

Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.

von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Côté AM, Douglas MJ, Gruslin A, Hutcheon JA, Joseph KS, Kyle PM, Lee T, Loughna P, Menzies JM, Merialdi M, Millman AL, Moore MP, Moutquin JM, Ouellet AB, Smith GN, Walker JJ, Walley KR, Walters BN, Widmer M, Lee SK, Russell JA, Magee LA; PIERS Study Group.

Lancet. 2011 Jan 15;377(9761):219-27. doi: 10.1016/S0140-6736(10)61351-7. Epub 2010 Dec 23.

PMID:
21185591
4.

Development and internal validation of a multivariable model to predict perinatal death in pregnancy hypertension.

Payne BA, Groen H, Ukah UV, Ansermino JM, Bhutta Z, Grobman W, Hall DR, Hutcheon JA, Magee LA, von Dadelszen P; miniPIERS working group.

Pregnancy Hypertens. 2015 Oct;5(4):315-21. doi: 10.1016/j.preghy.2015.08.006. Epub 2015 Aug 28.

5.

Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.

Akkermans J, Payne B, von Dadelszen P, Groen H, Vries Jd, Magee LA, Mol BW, Ganzevoort W.

Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:58-62. doi: 10.1016/j.ejogrb.2014.05.021. Epub 2014 Jun 2.

PMID:
24965981
6.

Assessing the incremental value of blood oxygen saturation (SpO(2)) in the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) Risk Prediction Model.

Payne BA, Hutcheon JA, Dunsmuir D, Cloete G, Dumont G, Hall D, Lim J, Magee LA, Sikandar R, Qureshi R, van Papendorp E, Ansermino JM, von Dadelszen P.

J Obstet Gynaecol Can. 2015 Jan;37(1):16-24.

PMID:
25764032
7.

Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort.

North RA, McCowan LM, Dekker GA, Poston L, Chan EH, Stewart AW, Black MA, Taylor RS, Walker JJ, Baker PN, Kenny LC.

BMJ. 2011 Apr 7;342:d1875. doi: 10.1136/bmj.d1875.

8.

Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study.

Thangaratinam S, Allotey J, Marlin N, Mol BW, Von Dadelszen P, Ganzevoort W, Akkermans J, Ahmed A, Daniels J, Deeks J, Ismail K, Barnard AM, Dodds J, Kerry S, Moons C, Riley RD, Khan KS.

Health Technol Assess. 2017 Apr;21(18):1-100. doi: 10.3310/hta21180.

9.

Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission.

Payne B, Hodgson S, Hutcheon JA, Joseph KS, Li J, Lee T, Magee LA, Qu Z, von Dadelszen P; PIERS Study Group.

BJOG. 2013 Jan;120(1):113-8. doi: 10.1111/j.1471-0528.2012.03496.x. Epub 2012 Oct 19.

10.

Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.

Myers JE, Kenny LC, McCowan LM, Chan EH, Dekker GA, Poston L, Simpson NA, North RA; SCOPE consortium.

BJOG. 2013 Sep;120(10):1215-23. doi: 10.1111/1471-0528.12195. Epub 2013 Mar 21.

11.

Proteinuria in pre-eclampsia: how much matters?

Chan P, Brown M, Simpson JM, Davis G.

BJOG. 2005 Mar;112(3):280-5.

12.

Validation of fullPIERS model for prediction of adverse outcomes among women with severe pre-eclampsia.

Almeida ST, Katz L, Coutinho I, Amorim MMR.

Int J Gynaecol Obstet. 2017 Aug;138(2):142-147. doi: 10.1002/ijgo.12197. Epub 2017 May 23.

PMID:
28475234
13.

Prediction of complications in early-onset pre-eclampsia (PREP): development and external multinational validation of prognostic models.

Thangaratinam S, Allotey J, Marlin N, Dodds J, Cheong-See F, von Dadelszen P, Ganzevoort W, Akkermans J, Kerry S, Mol BW, Moons KG, Riley RD, Khan KS; PREP Collaborative Network.

BMC Med. 2017 Mar 30;15(1):68. doi: 10.1186/s12916-017-0827-3.

14.

Mid-trimester beta-hCG levels incorporated in a multifactorial model for the prediction of severe pre-eclampsia.

Lee LC, Sheu BC, Shau WY, Liu DM, Lai TJ, Lee YH, Huang SC.

Prenat Diagn. 2000 Sep;20(9):738-43.

PMID:
11015703
15.

Performance of the Obstetric Early Warning Score in critically ill patients for the prediction of maternal death.

Paternina-Caicedo A, Miranda J, Bourjeily G, Levinson A, Dueñas C, Bello-Muñoz C, Rojas-Suarez JA.

Am J Obstet Gynecol. 2017 Jan;216(1):58.e1-58.e8. doi: 10.1016/j.ajog.2016.09.103. Epub 2016 Oct 15.

PMID:
27751799
16.

Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.

Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR.

Cochrane Database Syst Rev. 2014 Jun 24;(6):CD001059. doi: 10.1002/14651858.CD001059.pub4. Review.

PMID:
24960615
17.

First-trimester screening for preeclampsia: impact of maternal parity on modeling and screening effectiveness.

Moon M, Odibo A.

J Matern Fetal Neonatal Med. 2015;28(17):2028-33. doi: 10.3109/14767058.2014.978758. Epub 2014 Nov 11.

PMID:
25330843
18.

Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term.

Cluver C, Novikova N, Koopmans CM, West HM.

Cochrane Database Syst Rev. 2017 Jan 15;1:CD009273. doi: 10.1002/14651858.CD009273.pub2. Review.

PMID:
28106904
19.

Risk indicators for eclampsia in gestational hypertension or mild preeclampsia at term.

Koopmans CM, Zwart JJ, Groen H, Bloemenkamp KW, Mol BW, Van Pampus MG, Van Roosmalen J.

Hypertens Pregnancy. 2011;30(4):433-46. doi: 10.3109/10641955.2010.506236. Epub 2010 Sep 7.

PMID:
20822426
20.

Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study.

Yen TW, Payne B, Qu Z, Hutcheon JA, Lee T, Magee LA, Walters BN, von Dadelszen P.

J Obstet Gynaecol Can. 2011 Aug;33(8):803-9.

PMID:
21846435

Supplemental Content

Support Center